USPTO serial 79403391
VATRESSA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 14, 2026
- Examiner
- NEPTUNE, EVONNE MARIE
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with VATRESSA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Boris Umansky
Boris Umansky Ladas & Parry LLP224 S. Michigan Avenue, Ste. 1600Chicago, IL 60604United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Eye drops; ophthalmological preparations; pharmaceutical products and preparations for ophthalmological use; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; allergy capsules; capsules sold empty for pharmaceuticals; gelatin capsules, empty, for pharmaceuticals; eyepatches for medical purposes; bandages for dressings; liquid bandages for skin wounds; liquid bandage sprays; cotton swabs for medical purposes; dietary supplements for human beings; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies, namely, liquid formula for babies, powdered milk for babies; food for babies; all of the aforesaid products for use in association with ophthalmological use and not for use in association with hyperkalemia, renal, cardiovascular, gastrointestinal, endocrine, and potassium fields of use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SENJU PHARMACEUTICAL CO., LTD.
- Other trademarks owned by SENJU PHARMACEUTICAL CO., LTD.
- Other trademarks owned by SENJU PHARMACEUTICAL CO., LTD.
- Other trademarks in Class 005
- Similar marks named VATRESSA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 29, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Sep 15, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 15, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 10, 2026 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Sep 7, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 14, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 29, 2026 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Apr 17, 2026 | CHPN | POST PUBLICATION AMENDMENT – NOT ENTERED | — |
| Apr 14, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Apr 14, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 14, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 19, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Feb 19, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 12, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 27, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 27, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 26, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 11, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 7, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 7, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 7, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 20, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 20, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 9, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 8, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 8, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 4, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 4, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 29, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |